Investors NewsSearch: Jun 21, 2021Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company Jun 14, 2021Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results Jun 14, 2021Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors May 28, 2021Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 Apr 16, 2021Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 Mar 17, 2021Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results Mar 11, 2021Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO Dec 22, 2020Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program Dec 15, 2020Rafael Holdings Reports First Quarter Fiscal Year 2021 Results Oct 29, 2020Rafael Holdings Reports Fourth Quarter and Full Fiscal Year 2020 Results 1 2 3 4 5 6 << < > >>
